Single‐center analysis of antiresorptive agent‐related osteonecrosis of the jaw in lung cancer patients-Reference-Cited by-同舟云学术

Single‐center analysis of antiresorptive agent‐related osteonecrosis of the jaw in lung cancer patients

Published:2020-09-07 Issue:6 Volume:16 Page:380-384
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Okamura Misato¹,Fujita Kohei¹^ORCID,Yamamoto Yuki¹²,Kanai Osamu¹,Nakatani Koichi¹,Horimoto Kanna³,Hashimoto Masayuki³,Sawai Satoru³,Shimosato Maiko⁴,Yoshida Kazuya⁴,Mio Tadashi¹

Affiliation:

1. Division of Respiratory Medicine, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto Japan

2. Department of Drug Discovery for Lung Diseases, Graduate School of Medicine Kyoto University Kyoto Japan

3. Division of Thoracic Surgery, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto Japan

4. Department of Oral and Maxillofacial Surgery National Hospital Organization Kyoto Medical Center Kyoto Japan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13395

Reference17 articles.

1. Cancer statistics, 2019

2. The Japanese Lung Cancer Society. The Japanese Lung Cancer Society Guidelines for Diagnosis and Treatment of the Lung Cancer 2018.2018:1–394(In Japanese).

3. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

4. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis

5. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab;Cancer Medicine;2023-08-09

2. Survival of metastatic cancer and myeloma patients after diagnosis of Osteonecrosis of Jaws (ONJ). Potential impact on ONJ treatment strategies.;2021-04-11